COVID-19 ‘s associated coagulation disorder was characterized by increased levels of D-dimer and fibrinogen, and slight abnormalities in prothrombin time, activated partial thromboplastin time and platelet count at the initial stage of infection (9, 10). The gene discussed is F2; the disease is COVID-19.